palbociclib

FDA designates experimental Pfizer drug for common breast cancer type a breakthrough therapy
Yahoo/AP
Thu, 04/11/13 - 11:28 am
FDA
Pfizer
breast cancer
palbociclib
Pfizer’s Palbociclib (PD-0332991) Receives FDA Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer
Yahoo
Wed, 04/10/13 - 11:10 am
Pfizer
palbociclib
FDA
breast cancer
Pfizer's Next Big Deal Will Generate Income For Novartis, Prevent Competitors' Initiative
Seeking Alpha
Fri, 03/29/13 - 10:54 am
Pfizer
Novartis
breast cancer
palbociclib

Pages